Characteristics and outcomes of progressive multifocal leukoencephalopathy in hematologic malignancies and stem cell

Diego Adrianzen Herrera1, Sabarish Ayyappan2, Sakshi Jasra1

  • 1a Department of Medical Oncology, Albert Einstein College of Medicine/Montefiore Medical Center , Bronx , NY , USA.

Leukemia & Lymphoma
|July 4, 2018
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) is a serious risk following stem-cell transplants or chemoimmunotherapy for blood cancers. Patients undergoing stem-cell transplantation generally experience better outcomes and survival rates compared to those receiving other treatments.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Hematology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare but severe opportunistic infection affecting the brain.
  • It is a known complication of certain immunomodulatory therapies, particularly in patients with hematologic malignancies.
  • Understanding PML incidence and outcomes in this population is crucial for patient management.

Observation:

  • A review of 107 PML cases between 1995-2017 revealed patients undergoing stem-cell transplantation (HSCT) and those treated with monoclonal antibodies (mAbs) for hematologic malignancies.
  • HSCT recipients represented 40% of cases, as did patients with indolent lymphomas receiving mAbs.
  • PML diagnosis occurred later in HSCT recipients (10.8 months vs. 4 months).

Findings:

  • HSCT recipients showed a higher response rate to PML therapy (58% vs. 25%) and a lower mortality rate (56% vs. 88%) compared to other treatment groups.
  • Median survival was significantly longer for HSCT recipients (8 months vs. 2 months).
  • These outcome differences may be influenced by patient selection bias and immune reconstitution post-HSCT.

Implications:

  • The rising incidence of PML in hematologic malignancies, linked to increased use of mAbs and HSCT, positions this group as the second most vulnerable after HIV-infected patients.
  • Further research is essential to optimize treatment strategies and improve prognosis for PML in these immunocompromised individuals.
  • The findings highlight the need for vigilant monitoring and proactive management of PML in patients undergoing intensive therapies for blood cancers.

Related Concept Videos

Characteristics of Series Resonant Circuit01:24

Characteristics of Series Resonant Circuit

Series resonance occurs in a circuit containing inductive (L), capacitive (C), and resistive (R) elements connected sequentially. At the resonance frequency, the inductive and capacitive reactances are equal in magnitude but opposite in sign, effectively canceling each other. This causes the circuit's impedance is minimal, primarily determined by the resistance R. The resonant frequency of an RLC circuit is defined as:
652
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Characteristics of Life01:23

Characteristics of Life

Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
262.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.3K